BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 19010636)

  • 1. A prospective randomized trial: the influence of intraoperative application of fibrin glue after radical inguinal/iliacal lymph node dissection on postoperative morbidity.
    Neuss H; Raue W; Koplin G; Schwenk W; Reetz C; Mall JW
    Eur J Surg Oncol; 2009 Aug; 35(8):884-9. PubMed ID: 19010636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surgical technique and postoperative morbidity following radical inguinal/iliacal lymph node dissection--a prospective study in 67 patients with malignant melanoma metastatic to the groin].
    Mall JW; Reetz C; Koplin G; Schäfer-Hesterberg G; Voit C; Neuss H
    Zentralbl Chir; 2009 Sep; 134(5):437-42. PubMed ID: 19757344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does administration of fibrin glue prevent development of lymphoceles after radical lymphadenectomy?].
    Furrer M; Inderbitzi R; Nachbur B
    Chirurg; 1993 Dec; 64(12):1044-9. PubMed ID: 8119091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative application of fibrin sealant does not reduce the duration of closed suction drainage following radical axillary lymph node dissection in melanoma patients: a prospective randomized trial in 58 patients.
    Neuss H; Raue W; Koplin G; Schwenk W; Reetz C; Mall JW
    World J Surg; 2008 Jul; 32(7):1450-5. PubMed ID: 18373121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fibrin glue on lymphatic drainage after modified radical mastectomy: a prospective randomized trial.
    Dinsmore RC; Harris JA; Gustafson RJ
    Am Surg; 2000 Oct; 66(10):982-5. PubMed ID: 11261630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?
    Langer S; Guenther JM; DiFronzo LA
    Am Surg; 2003 Jan; 69(1):77-81. PubMed ID: 12575787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients.
    Cipolla C; Fricano S; Vieni S; Graceffa G; Licari G; Torcivia A; Latteri MA
    J Surg Oncol; 2010 Jun; 101(7):600-3. PubMed ID: 20461767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of fibrin glue after axillary lymphadenectomy in the surgical treatment of human breast cancer.
    Medl M; Mayerhofer K; Peters-Engl C; Mahrhofer P; Huber S; Buxbaum P; Sevelda P; Leodolter S
    Anticancer Res; 1995; 15(6B):2843-5. PubMed ID: 8669876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological glue does not reduce lymphorrhoea after lymph node excision. Randomized prospective study on 40 patients].
    Vaxman F; Kolbe R; Stricher F; Boullenois JN; Volkmar P; Gros D; Grenier JF
    Ann Chir; 1995; 49(5):411-6. PubMed ID: 7574352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin sealant reduces serous drainage and allows for earlier drain removal after axillary dissection: a randomized prospective trial.
    Moore MM; Nguyen DH; Spotnitz WD
    Am Surg; 1997 Jan; 63(1):97-102. PubMed ID: 8985079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial.
    Carcoforo P; Soliani G; Maestroni U; Donini A; Inderbitzin D; Hui TT; Lefor A; Avital I; Navarra G
    J Am Coll Surg; 2003 Mar; 196(3):365-9. PubMed ID: 12648685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.
    de Vries M; Vonkeman WG; van Ginkel RJ; Hoekstra HJ
    Eur J Surg Oncol; 2006 Sep; 32(7):785-9. PubMed ID: 16806794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).
    Mortenson MM; Xing Y; Weaver S; Lee JE; Gershenwald JE; Lucci A; Mansfield PF; Ross MI; Cormier JN
    World J Surg Oncol; 2008 Jun; 6():63. PubMed ID: 18564433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radical prostatectomy and biologic glue].
    Lobel B; Ordonez O; Olivo JF; Cipolla B; Milon D; Leveque JM; Guille F
    Prog Urol; 1991 Jun; 1(3):440-4. PubMed ID: 1844718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half versus full vacuum suction drainage after modified radical mastectomy for breast cancer- a prospective randomized clinical trial[ISRCTN24484328].
    Chintamani ; Singhal V; Singh J; Bansal A; Saxena S
    BMC Cancer; 2005 Jan; 5():11. PubMed ID: 15676064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic groin dissection for melanoma: risk factors for short term morbidity.
    Poos HP; Kruijff S; Bastiaannet E; van Ginkel RJ; Hoekstra HJ
    Eur J Surg Oncol; 2009 Aug; 35(8):877-83. PubMed ID: 19054644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of fibrin glue on seroma formation after breast surgery.
    Johnson L; Cusick TE; Helmer SD; Osland JS
    Am J Surg; 2005 Mar; 189(3):319-23. PubMed ID: 15792759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of fibrin sealant to reduce postoperative drainage following elective lymph node dissection.
    Swan MC; Oliver DW; Cassell OC; Coleman DJ; Williams N; Morritt DG; Giele HP
    Br J Surg; 2011 Jul; 98(7):918-24. PubMed ID: 21456091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New trends on fibrin glue in seroma after axillary lymphadenectomy for breast cancer.
    Ruggiero R; Procaccini E; Gili S; Cremone C; Parmeggiani D; Conzo G; Docimo L; Sparavigna L; Gubitosi A; Docimo G; Sanguinetti A; Avenia N
    G Chir; 2009; 30(6-7):306-10. PubMed ID: 19580713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.
    Carlson JW; Kauderer J; Walker JL; Gold MA; O'Malley D; Tuller E; Clarke-Pearson DL;
    Gynecol Oncol; 2008 Jul; 110(1):76-82. PubMed ID: 18482765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.